Overview Request Sample Pages Request Customization Download PDF
You are viewing: Australia Genomics Market analysis
Part of: Genomics Market (Global)

The Australia Genomics Market was valued at $10163.7 Million in 2025 and projected to reach to $16586.9 Million by 2030, representing a compound annual growth rate of CAGR 10.3%. Australia's genomics market is positioned for robust expansion through 2030, with the PCR segment playing a pivotal role in advancing diagnostic capabilities across clinical, research, and forensic applications.

Australia Genomics Market Trends and Insights

  • Pcr's sustained growth trajectory reflects its indispensable role in DNA amplification, diagnostic testing, and research applications across clinical and laboratory settings.
  • The Pcr segment is experiencing accelerated adoption driven by rising demand for genetic testing, infectious disease detection, and personalized medicine initiatives throughout the forecast period. The Pcr technology segment demonstrates robust market fundamentals, with a compound annual growth rate of 10.3% between 2025 and 2030.
  • Pcr continues to benefit from technological innovations, including digital Pcr and real-time Pcr platforms, which enhance sensitivity and throughput.
  • Pcr's market expansion is further supported by increased healthcare spending, growing prevalence of genetic disorders, and the integration of Pcr into routine diagnostic workflows globally..

Key Market Statistics

  • CAGR (2025-2030) CAGR 10.3%
  • Market Size, 2025 ~USD 10163.7 Million
  • Forecast, 2030 ~USD 16586.9 Million
  • Country Australia

Australia Genomics Market Overview

Strong Local Growth Momentum :

Australia's genomics market is expanding at 10.3% CAGR, driven by increasing adoption of PCR technologies in diagnostic laboratories and research institutions across major cities including Sydney, Melbourne, and Brisbane.

Clinical Diagnostics Expansion :

Australian healthcare providers are rapidly integrating PCR-based genomic testing for infectious disease detection, cancer diagnostics, and personalized medicine, supported by government healthcare funding and private sector investment.

Research & Development Hub :

Australia's leading universities and research institutions are investing heavily in genomic research capabilities, creating sustained demand for advanced PCR equipment and reagents in academic and commercial laboratories.

Regulatory Support & Infrastructure :

The National Pathology Accreditation Advisory Council (NPAAC) and NATA accreditation standards are driving standardization and quality improvements in genomic testing, supporting market professionalization and growth.

Australia Genomics Market Dynamics

  • The market's 10.3% CAGR reflects growing healthcare investments, increased prevalence of genetic testing, and strengthening partnerships between Australian institutions and global genomics leaders. Key growth drivers include rising demand for precision medicine, expansion of pathology networks, and government initiatives supporting genomic research infrastructure.
  • Australian laboratories are increasingly adopting automated PCR platforms to enhance throughput and accuracy, while regulatory frameworks continue to support innovation and quality standards in genomic testing services..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • Danaher Corporation

    Biotechnology

    Top Technologies
    • Reagents
    • Polymerase Chain Reaction (PCR)
    • Stem Cells
    • Assay Kits
    • Flow Cytometers
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.

      Key Takeaways

      • Pcr segment valued at $10,163.7M in 2025, expanding to $16,586.9M by 2030 at 10.3% CAGR
      • Pcr technology drives diagnostic accuracy and enables rapid pathogen detection across clinical laboratories
      • Pcr adoption accelerates through digital and real-time innovations enhancing sensitivity and automation
      • Pcr market growth supported by personalized medicine trends and increased genetic testing demand

      Genomics Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment SERVICES (Offering)
      Forecast Period 2025–2030
      Growth Rate CAGR of 12.6% from 2025 to 2030
      Largest Segment PRODUCTS (Offering)
      Market Size Base Year (Billions) ~USD 47.01 (2025)
      Revenue Forecast (Billions) ~USD 85.09 (2030)
      Segments Covered Offering, Type, Technology, End User, Study Type, Application

      Australia Genomics Market Report Segmentation

      6 segment dimensions are covered across the global market.

      By Offering

      • Products
      • Services

      By Type

      • Bioinformatics Services
      • Bioinformatics Tools
      • Cancer Diagnostics
      • Genomic Profiling & Sequencing Services
      • Infectious Disease Diagnostics
      • Instruments
      • Other Diagnostic Applications
      • Reagents, Kits, And Consumables
      • Reproductive Health Diagnostics
      • Sample Preparation & Library Preparation Services

      By Technology

      • Flow Cytometry
      • Gene Editing
      • In Situ Hybridization
      • Microarrays
      • Other Technologies
      • Pcr
      • Sequencing

      By End User

      • Academic & Research Institutes
      • Cros
      • Hospitals, Diagnostic Laboratories, And Clinics
      • Other End Users
      • Pharmaceutical & Biotechnology Companies

      By Study Type

      • Biomarker Discovery
      • Epigenomics
      • Functional Genomics
      • Other Study Types
      • Pathway Analysis

      By Application

      • Agriculture & Animal Research
      • Diagnostics
      • Drug Discovery & Development
      • Other Applications

      Target Audience

      • Diagnostic Laboratory Operators : Need market data to evaluate PCR technology investments, benchmark operational performance against Australian peers, and plan capacity expansion to meet growing demand for genomic testing services.
      • Medical Device & Reagent Manufacturers : Require Australia-specific market insights to assess commercial viability, identify distribution partnerships, develop localized product strategies, and forecast revenue potential in the growing genomics segment.
      • Healthcare Investment & Private Equity Firms : Seek comprehensive market analysis to evaluate acquisition targets, assess growth potential of Australian pathology and genomics companies, and make informed investment decisions in the healthcare sector.
      • Research Institutions & Universities : Need market intelligence to justify funding requests, identify collaboration opportunities with commercial entities, and understand technology trends shaping genomic research capabilities and infrastructure requirements.
      • Healthcare Policy & Government Agencies : Require data-driven insights to inform healthcare policy decisions, allocate research funding, support precision medicine initiatives, and develop regulatory frameworks for genomic testing and personalized medicine in Australia.

      Key Companies in the Australia Genomics Market

      CompanyHQOwnershipStrongest segments
      ABCAM PLCUnited KingdomPrivate CompanyReagents (antibodies, proteins, peptides, biochemicals),Kits (conjugation, cellular activity, pathway tools, immunoassays),Instruments and tools-adjacent products,
      AFFYMETRIX INCUnited StatesPrivate CompanyReagents,Kits,Instruments,
      BECKMAN COULTERUnited StatesPrivate CompanyInstruments (flow cytometers, centrifuges, capillary electrophoresis, liquid handlers, analyzers),Reagents & Kits (sample prep, library construction, single-cell PCR, immunoassay),Genome Profiling & Genomic Services,
      CEPHEID INC.United StatesPrivate CompanyInstruments (GeneXpert, SmartCycler),Reagents & Kits (Xpert tests and related consumables),Services (Genome profiling, bioinformatics, support),
      CORNING, INC.United StatesPublic CompanyReagents and Kits,Instruments and Lab Equipment,Labware and Specialty Surfaces for Genomics,
      DECODE GENETICSIcelandPrivate CompanyReagents,Kits,Instruments,
      GENOMIC HEALTH INCUnited StatesPrivate CompanyGenomic-based diagnostic services (oncology),Genome profiling services beyond core oncology,Bioinformatics and data-related services,
      UNILABSSwitzerlandPrivate CompanyReagents,Kits,Instruments,
      MAXCYTE, INCUnited StatesPublic CompanyInstruments (ExPERT ATx, STx, GTx, VLx),Consumables (Processing Assemblies, buffers, accessories),Licensing and technology access,
      DANAHER CORPORATIONUnited StatesPublic CompanyReagents and Kits,Instruments (Sequencing-adjacent, PCR, Flow Cytometry, Sample Prep),Services (Genome Profiling, Bioinformatics, Custom Development),
      AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyInstruments (sequencing-adjacent, PCR, flow cytometry, ISH platforms),Reagents and Kits,Genomics Services (Genome Profiling, CDMO, and Lab Services),
      REVVITYUnited StatesPublic CompanyReagents & Kits,Instruments,Genome Profiling Services,
      LABORATORY CORPORATION OF AMERICA HOLDINGSUnited StatesPublic CompanyReagents,Kits,Instruments,
      IQVIA INC.United StatesPublic CompanyGenomics Services – Genome Profiling & Central Labs,Bioinformatics & Real-World Genomics Analytics,Genomics-Enabled Clinical Research Services,
      CHARLES RIVER LABORATORIESUnited StatesPublic CompanyReagents,Kits,Instruments,
      BIO-RAD LABORATORIES, INC.United StatesPublic CompanyReagents,Kits,Instruments,
      EUROFINS SCIENTIFICLuxembourgPublic CompanyReagents,Kits,Instruments,
      PACBIOUnited StatesPublic CompanyInstruments (Revio, Sequel, Vega, Onso),Reagents & Kits (SMRT cells, prep, binding, sequencing kits),Services (Genome profiling, bioinformatics and related),
      OXFORD NANOPORE TECHNOLOGIES PLC.United KingdomPublic CompanyInstruments (MinION, GridION, PromethION family),Reagents & Kits,Genome Profiling & Sequencing Services,
      TAKARA BIO INC.JapanPrivate CompanyReagents,Kits,Instruments,

      ABCAM PLC

      Abcam PLC is a United Kingdom-based private company founded in 1998 with 1,760 employees that develops and supplies research reagents and tools for the life sciences industry.

      AFFYMETRIX INC

      Affymetrix Inc. is a United States-based private company founded in 1991 with 1,150 employees focused on molecular biology and genomic analysis technologies.

      BECKMAN COULTER

      Beckman Coulter is a United States-based private company founded in 1935 with 11,900 employees that manufactures and distributes laboratory instruments and diagnostic equipment.

      CEPHEID INC.

      Cepheid Inc. is a United States-based private company founded in 1996 with 1,700 employees that develops molecular diagnostic systems and point-of-care testing solutions.

      CORNING, INC.

      Corning, Inc. is a United States-based public company founded in 1851 with 67,200 employees that manufactures specialty glass, ceramics, and laboratory equipment.

      DECODE GENETICS

      deCODE Genetics is an Iceland-based private company founded in 1996 with 331 employees focused on genomic research and genetic analysis.

      GENOMIC HEALTH INC

      Genomic Health Inc. is a United States-based private company founded in 2000 with 829 employees specializing in genomic-based diagnostic testing.

      UNILABS

      Unilabs is a Switzerland-based private company founded in 1987 with 1,897 employees providing clinical laboratory and diagnostic testing services.

      MAXCYTE, INC

      MaxCyte, Inc. is a United States-based public company founded in 1998 with 91 employees developing cell engineering and electroporation technologies.

      DANAHER CORPORATION

      Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees operating a diversified portfolio of businesses including life sciences and diagnostics.

      AGILENT TECHNOLOGIES, INC.

      Agilent Technologies, Inc. is a United States-based public company founded in 1999 with 18,000 employees manufacturing analytical instruments and life sciences equipment.

      REVVITY

      Revvity is a United States-based public company founded in 1937 with 11,000 employees providing analytical instruments and life sciences solutions.

      LABORATORY CORPORATION OF AMERICA HOLDINGS

      Laboratory Corporation of America Holdings is a United States-based public company founded in 1995 with 66,385 employees operating one of the largest clinical laboratory networks.

      IQVIA INC.

      IQVIA Inc. is a United States-based public company with 93,000 employees providing clinical research, data analytics, and technology solutions to the pharmaceutical and healthcare industries.

      CHARLES RIVER LABORATORIES

      Charles River Laboratories is a United States-based public company founded in 1947 with 19,000 employees providing preclinical and clinical laboratory services for drug development.

      BIO-RAD LABORATORIES, INC.

      Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees manufacturing and distributing life science research and clinical diagnostic products.

      EUROFINS SCIENTIFIC

      Eurofins Scientific is a Luxembourg-based public company founded in 1987 with 65,694 employees providing laboratory testing and analytical services across multiple industries.

      PACBIO

      PacBio is a United States-based public company founded in 2000 with 485 employees developing long-read DNA sequencing technologies.

      OXFORD NANOPORE TECHNOLOGIES PLC.

      Oxford Nanopore Technologies PLC. is a United Kingdom-based public company founded in 2005 with 1,316 employees specializing in nanopore-based DNA and RNA sequencing technologies.

      TAKARA BIO INC.

      Takara Bio Inc. is a Japan-based private company founded in 2002 with 1,779 employees providing molecular biology reagents and biotechnology products.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise market valuation data for Australia ($10.16B in 2025) with verified 10.3% CAGR projections through 2030, enabling accurate financial forecasting and investment decision-making for regional expansion strategies.
      • Competitive Landscape Intelligence : Understand Australia-specific market dynamics, key players, and competitive positioning within the PCR and genomics sector to identify partnership opportunities and market entry strategies tailored to local conditions.
      • Regulatory & Compliance Framework : Access detailed insights into Australian regulatory requirements, NATA accreditation standards, and healthcare reimbursement policies essential for product development, market registration, and commercial operations.
      • Customer Segmentation & Demand Drivers : Identify high-value customer segments including pathology networks, research institutions, and clinical laboratories with specific needs, enabling targeted marketing and sales strategies for maximum ROI in the Australian market.
      • Strategic Growth Opportunities : Discover emerging opportunities in precision medicine, infectious disease diagnostics, and genomic research infrastructure investments that align with Australian healthcare priorities and government funding initiatives.

      Frequently asked questions

      What is the market size of Pcr in 2025?

      The Pcr segment is valued at $10,163.7 million in 2025, representing a significant portion of the global genomics market.

      What is the projected Pcr market size by 2030?

      Pcr is forecast to reach $16,586.9 million by 2030, reflecting a 10.3% compound annual growth rate over the forecast period.

      What drives growth in the Pcr segment?

      Pcr growth is driven by increasing demand for genetic testing, infectious disease diagnostics, personalized medicine adoption, and technological innovations in digital and real-time Pcr platforms.

      What is the CAGR for Pcr technology?

      The Pcr segment exhibits a compound annual growth rate of 10.3% from 2025 to 2030.

      Which applications dominate the Pcr market?

      Pcr applications span clinical diagnostics, infectious disease detection, genetic testing, research laboratories, and forensic analysis, with clinical diagnostics representing the largest segment.

      RESEARCH METHODOLOGY

      This research study utilized extensive secondary sources, directories, and databases to identify and collect valuable information for analyzing the global genomics market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to gather and verify critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

      Secondary Research

      Secondary research was primarily used to identify and collect information for the comprehensive, technical, market-oriented, and commercial study of the genomics market. The secondary sources used for this study include Nucleic Acids Research, Genome Biology, the International Journal of Genomics, the National Human Genome Research Institute (NHGRI), the International Chromosome and Genome Society (ICGS), Genome Canada, the European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, the Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), Nature Reviews Genetics, Nature Methods, the Biotechnology and Biological Sciences Research Council (BBSRC), the Organisation for Economic Co-operation and Development (OECD), Genome Research, the National Cancer Institute (NCI), the European Medicines Agency (EMA), the Population Health Research Institute (PHRI), PubMed, World Bank, the World Health Organization (WHO), Eurostat, and Factiva; research journals; corporate filings, such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, and professional associations, among others. These sources were also utilized to gather key information about major players, market classification, and segmentation, as well as industry trends, regional/country-level markets, market developments, and technological perspectives.

      Primary Research

      After acquiring foundational knowledge about the global genomics market through secondary research, extensive primary research was conducted. Multiple interviews were held with market experts from the demand side, including representatives from academic & research institutes, hospitals, clinics & diagnostic labs, pharmaceutical & biopharmaceutical industries, CROs, and other end users. Additionally, experts from the supply side were interviewed, including C-level and D-level executives, product managers, and marketing and sales managers from key manufacturers, distributors, and channel partners.

      These interviews spanned six major regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while the remaining 30% were with demand-side participants. The primary data was collected through various methods, including questionnaires, emails, online surveys, personal interviews, and telephone interviews.

      The following is a breakdown of the primary respondents:

      Genomics Market Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the genomics market. These methods were also used extensively to estimate the size of various market segments. The research methodology used to estimate the market size includes the following:

      After determining the overall market size through the estimation process, the total market was divided into several segments and subsegments.

      Genomics Market : Top-Down and Bottom-Up Approach

      Genomics Market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      Genomics is a branch of molecular biology that involves the study of the structure, function, evolution, and mapping of genomes. It applies the techniques of genetics, molecular biology, and bioinformatics to sequence, assemble, and analyze the function and structure of the genome of a selected organism for analysis. Genomics is widely used in diagnostics, drug discovery and development, animal and agricultural research, forensics, and aquaculture research, among others.

      Key Stakeholders

      • Genomics Equipment and Consumable Manufacturing Companies
      • Genomics Instrument/System Manufacturing Companies
      • Suppliers and Distributors of Genomic Instruments/Systems, Consumables, and Services
      • Hospitals, Diagnostic Centers, and Medical Colleges
      • Research Institutes
      • Hospitals and Academic Medical Centers (AMCs)
      • Government Bodies/Municipal Corporations
      • Business Research Firms
      • Venture Capitalists
      • Pharmaceutical and Biopharmaceutical Companies

      Report Objectives

      • To define, describe, and forecast the genomics market based on offering, product type, service type, product by technology, application, end user by product, end user by service, and region, in terms of value
      • To forecast the size of the market segments with respect to six main regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa, in terms of value
      • To provide detailed information regarding the major factors influencing market growth, such as drivers, restraints, opportunities, and challenges
      • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall genomics market
      • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To profile key players in the genomics market and comprehensively analyze their product and service portfolios, market positions, and core competencies
      • To track and analyze competitive developments in the genomics market, such as acquisitions, product & service launches, expansions, agreements, partnerships, and collaborations
      • To benchmark players within the genomics market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business strategy and product strategy

      Available Customizations

      With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for this report:

      Portfolio Assessment

      • Product Matrix, which gives a detailed comparison of the product & service portfolios of the top three companies.

      Company Information

      • Detailed analysis and profiling of additional market players (up to three).

      Geographical Analysis

      • A further breakdown of the Rest of Asia Pacific genomics market into countries
      • A further breakdown of the Rest of Europe genomics market into countries
      • A further breakdown of the Rest of Latin America genomics market into countries
      • A further breakdown of the Rest of Middle East genomics market into countries

       

      Get the Full Genomics Market Report

      Full forecast, segment splits, and company analysis for all Genomics Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status